UPDATE 1-Cell Therapeutics starts late-stage Xyotax study
U.S.-Italian drug firm Cell Therapeutics Inc has begun a late-stage clinical trial involving its Xyotax drug for women with an advanced form of lung cancer, the company said on Monday.
This entry was posted on Wednesday, September 26th, 2007 at 12:02 pm and is filed under Research. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.